Israel medical cannabis producer Panaxia Labs Israel (TASE: PNAX) and European pharmaceutical company Neuraxpharm are planning to reach the French market.
The two companies have agreed to a production, marketing, and delivery partnership to distribute Panaxia’s medical cannabis products across France.
The new deal is similar to the one the companies made for Germany. This means Panaxia will be in charge of the product production, while Neuraxpharm will take over commercialization, branding, delivery, and sales.
Per the arrangement, the companies will first propose a joint response to the tender issued by the French government and the French National Agency for Medicines and Health Products Safety (ANSM) …